Repeated intrathecal triamcinolone acetonide application in multiple sclerosis patients: clinical aspects and effects on cerebrospinal fluid marker of astrocytic activation

被引：0
|
作者：
Abu-Mugheisib, M.
Tumani, H.
Petzold, A.
Kamin, F.
Winkelmann, A.
Koehler, W.
Hoffmann, F.
Benecke, R.
Zettl, U. K.
机构：
[1] Univ Rostock, Rostock, Germany
[2] Univ Ulm, Ulm, Germany
[3] UCL, London, England
[4] Saechs Krankenhaus Hubertusburg, Wermsdorf, Germany
[5] Krankenhaus Martha Maria Halle Doelau, Halle, Germany
来源：
MULTIPLE SCLEROSIS | 2009年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [1] Effects on cerebrospinal fluid biomarkers of immunological activation in multiple sclerosis patients after repeated intrathecal triamcinolone acetonid application
    Abu-Mugheisib, M.
    Tumani, H.
    Kamin, F.
    Apel, A.
    Koehler, W.
    Hoffmann, F.
    Benecke, R.
    Zettl, U. K.
    JOURNAL OF NEUROLOGY, 2007, 254 : 188 - 188
  • [2] Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
    P. S. Rommer
    F. Kamin
    A. Petzold
    H. Tumani
    M. Abu-Mugheisib
    W. Koehler
    F. Hoffmann
    A. Winkelmann
    R. Benecke
    U. K. Zettl
    Molecular Diagnosis & Therapy, 2014, 18 : 631 - 637
  • [3] Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
    Rommer, P. S.
    Kamin, F.
    Petzold, A.
    Tumani, H.
    Abu-Mugheisib, M.
    Koehler, W.
    Hoffmann, F.
    Winkelmann, A.
    Benecke, R.
    Zettl, U. K.
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (06) : 631 - 637
  • [4] Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients
    Hoffmann, V
    Schimrigk, S
    Islamova, S
    Hellwig, K
    Lukas, C
    Brune, N
    Pöhlau, D
    Przuntek, H
    Müller, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 211 (1-2) : 81 - 84
  • [5] Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms
    Kerstin Hellwig
    Franz Josef Stein
    Horst Przuntek
    Thomas Müller
    BMC Neurology, 4
  • [6] Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms
    Hellwig, Kerstin
    Stein, Franz Josef
    Przuntek, Horst
    Mueller, Thomas
    BMC NEUROLOGY, 2004, 4 (1)
  • [7] Effects of Repeated Intrathecal Triamcinolone Acetonid Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
    Abu-Mugheisib, Mazen M. K.
    Tumani, Hayrettin
    Petzold, Axel
    Kamin, Frank
    Koehler, Wolfgang
    Hoffmann, Frank
    Benecke, Reiner
    Zettl, Uwe K.
    NEUROLOGY, 2009, 72 (11) : A198 - A198
  • [8] Reduction in the Free Radical Status and Clinical Benefit of Repeated Intrathecal Triamcinolone Acetonide Application in Patients With Progressive Multiple Sclerosis
    Mueller, Thomas
    Herrling, Thomas
    Luetge, Sven
    Kuechler, Matthias
    Lohse, Lutz
    Rothe, Hartmut
    Haas, Thomas
    Marg, Marion
    Oehm, Gabi
    Jung, Katinka
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (01) : 22 - 25
  • [9] Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
    Hoeflich, Andreas
    Fitzner, Brit
    Walz, Christina
    Hecker, Michael
    Tuchscherer, Armin
    Bastian, Manuela
    Brenmoehl, Julia
    Schroeder, Ina
    Willenberg, Holger S.
    Reincke, Martin
    Zettl, Uwe Klaus
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [10] Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review
    Abu-Mugheisib, Mazen
    Benecke, Reiner
    Zettl, Uwe K.
    MULTIPLE SCLEROSIS INTERNATIONAL, 2011, 2011
12345